David Liu is best known as one of the pioneers of the experimental science of editing people’s genes. Liu’s laboratory at the Broad Institute of MIT and Harvard was the birthplace of two new types of gene-editing called base and prime editing, that swap out segments of the DNA strand without cutting into it. He and other […]

Glympse Bio has developed a liquid biopsy with the potential to diagnose and monitor non-alcoholic steatohepatitis (NASH) with significantly higher accuracy and less invasiveness than needle biopsies, according to a late-breaking presentation at the American Association for the Study of Liver Disease (AASLD) annual The Liver Meeting, held virtually November 12-15. This liquid biopsy uses a panel […]

In the phase 2 RESCUE-ALS clinical trial (NCT04098406), individuals early amyotrophic lateral sclerosis (ALS) who were treated with nanocrystalline gold for 12 weeks had improvement in their Motor Unit Number Index (MUNIX) compared with placebo. In a prespecified subset of participants with limb-onset ALS, MUNIX number and forced vital capacity (FVC) improved after 12 weeks […]